✦ LIBER ✦

Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy

✍ Scribed by Samuel Bral; Michaël Duchateau; Harijati Versmessen; Douwe Verdries; Benedikt Engels; Mark De Ridder; Koen Tournel; Christine Collen; Hendrik Everaert; Denis Schallier; Jacques De Greve; Guy Storme

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 224 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24732

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan and cisplatin with concurrent

Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer : A multiinstitutional phase 2 study

✍ Minoru Fukuda; Hiroshi Soda; Masaaki Fukuda; Akitoshi Kinoshita; Yoichi Nakamura 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract ## BACKGROUND. The purpose was to determine the efficacy and toxicity of irinotecan and cisplatin with concurrent split‐course thoracic radiotherapy (TRT) in locally advanced nonsmall‐cell lung cancer. ## METHODS. Fifty patients fulfilling the following eligibility criteria were enro

Dose escalation of gemcitabine concomita

Dose escalation of gemcitabine concomitant with radiation and cisplatin for nonsmall cell lung cancer : A phase 1-2 study

✍ Felix Momm; Markus Kaden; Ian Tannock; Martin Schumacher; Joachim Hasse; Michael 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

A phase 2 study of cetuximab in combinat

A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer

✍ Edward S. Kim; Ann M. Mauer; William N. William Jr; Hai T. Tran; Diane Liu; Jack 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

A front-line window of opportunity phase

A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer : North Central Cancer Treatment Group Study N0326

✍ Grace K. Dy; Shauna L. Hillman; Kendrith M. Rowland Jr; Julian R. Molina; Presto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

Randomized phase 2 study of irinotecan p

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer

✍ Ji-Youn Han; Dae Ho Lee; Jung Eun Song; Sung Young Lee; Hyae Young Kim; Heung Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

High-dose intra-arterial cisplatin and c

High-dose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: Report of a phase II study

✍ William F. Regine; Joseph Valentino; William John; Gayle Storey; David Sloan; Da 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views